Commentary on “A phase II study of oportuzumab monatox: An immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin.” Kowalski M, Guindon J, Brazas L, Moore C, Entwistle J, Cizeau J, Jewett MA, MacDonald GC

✍ Scribed by See, William A.

• Book ID: 122341466
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 119 KB
• Volume: 31
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2013.03.016